Welcome to the IRIS Community
Community for Sustainable Inhaled Respiratory Medicines
We are a community of clinicians and other stakeholders interested in protecting patient access and defending clinical choice, whilst supporting environmental sustainability.
Join Us
Join our community to stay informed about critical developments that could impact patient access to inhaled respiratory medicines, such as proposed per- and polyfluoroalkyl substances (PFAS) policies.
As a member, you'll gain access to valuable tools and resources that empower you to respond to and understand key sustainability issues surrounding these medicines.
Membership is open to respiratory clinicians, environmental toxicologists, patient advocacy groups, and industry partners.
You'll receive updates from IRIS, ensuring you keep up to date with emerging research and ways to support sustainable access to essential inhaled medications.